Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Neutra Corp.
- Market Cap
- Unavailable
- Volume
- 30.0K
Quote data as of 7:04 AM ET
About
Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.
Quick stats
Shares outstanding—
Computed float2.9B
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001512886
Websitehttps://neutrainc.com
AI Summary
AI-generated10d agominorbullishpartnershipNeutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio
Neutra Corp’s subsidiary Neutra Life Sciences formed a joint venture with the Women’s Healthcare Center of Baytown to expand its site network into women’s health.
The subsidiary was also awarded new clinical trials in Oncology, Dermatology, Pulmonology, and Women’s Health while securing contracts with new sponsors.
Management indicated that these milestones mark a transition from an early-growth phase to a stable operating model capable of scaling trial volume for the remainder of 2026.